Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-24-015042
Filing Date
2024-04-05
Accepted
2024-04-05 16:14:19
Documents
1
Period of Report
2024-04-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1712348050.html 4  
1 FORM 4 wk-form4_1712348050.xml 4 7353
  Complete submission text file 0001628280-24-015042.txt   9094
Mailing Address C/O VIROLOGIC 345 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address
HIBBS KATHY L (Reporting) CIK: 0001267487 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39587 | Film No.: 24826674

Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Issuer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)